Countries China
According to a disclosure by the Shanghai Public Health Clinical Center on June 6, 2023, an epidemiological survey of DED showed that approximately 34...
November 30, 2023 | News
Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...
November 30, 2023 | News
--Nefecon® is the first approved medicine with an IgAN indication in China-- --The approval marks a new era of IgAN treatment for Chinese patient...
November 27, 2023 | News
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK- DxVx plans to proceed its own clinical trials in Asia, including Korea and Chi...
November 27, 2023 | News
The outbreak initially surfaced in northern China, prompting the World Health Organization (WHO) to issue an "official request" to ...
November 27, 2023 | News
Pursuant to the Agreement, Simcere obtains the exclusive rights in the development, manufacturing, and commercialization of Rademikibart for all indication...
November 24, 2023 | News
“We are committed to developing novel molecules with the potential to transform the therapeutic landscape for cancer patients, and this partnership f...
November 23, 2023 | News
By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture...
November 23, 2023 | News
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
November 23, 2023 | News
Building upon an ongoing collaboration that was initiated in December 2022 to utilize artificial intelligence (AI) and automation to develop targ...
November 22, 2023 | News
On June 30, 2023, the China National Medical Products Administration (NMPA) approved the marketing of Equecabtagene Autoleucel Injection (brand name: FUCAS...
November 22, 2023 | News
Porton Advanced is committed to providing end-to-end gene and cell therapy CDMO services, covering fields such as plasmids, cell therapy, gene therapy, and...
November 21, 2023 | News
WuXi XDC issued a total of 178,446,000 shares under the global offering at an offer price of HK$20.60 per share (being the high-end of the indica...
November 20, 2023 | News
This cutting-edge platform surpasses conventional methods, enabling the screening of thousands of innovative lead molecules against common targets. Sanyou ...
November 20, 2023 | News
Most Read
Bio Jobs
News
Editor Picks